KOD (STOCKS)
Kodiak Sciences Inc Common Stock
$41.950000
-1.160000 (-2.69%)
Prev close: $43.110000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Victor Perlroth
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2,592.05M
- Employees
- 121
- P/E (TTM)
- -9.70
- P/B (TTM)
- 16.46
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
7
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-1.04 | $-1.06 | +0.0239 | +2.25% |
|
Sep 2025 (Q3)
|
$-1.16 | $-1.04 | -0.1207 | -11.61% |
|
Jun 2025 (Q2)
|
$-1.03 | $-1.08 | +0.0477 | +4.43% |
|
Mar 2025 (Q1)
|
$-1.09 | $-0.90 | -0.1871 | -20.72% |
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $234.39M |
| Research and Development | $182.37M |
| Other Operating Expenses | $52.02M |
| Operating Income/Loss | -$234.39M |
| Income/Loss From Continuing Operations After Tax | -$229.97M |
| Income/Loss From Continuing Operations Before Tax | -$229.92M |
| Income Tax Expense/Benefit | $52.00K |
| Interest Expense, Operating | $0.00 |
| Net Income/Loss | -$229.97M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$229.97M |
| Net Income/Loss Available To Common Stockholders, Basic | -$229.97M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$4.32 |
| Diluted Earnings Per Share | -$4.32 |
| Basic Average Shares | 53,208,311 |
| Diluted Average Shares | 53,208,311 |
| Assets | $351.53M |
| Current Assets | $214.82M |
| Noncurrent Assets | $136.72M |
| Fixed Assets | $85.26M |
| Other Non-current Assets | $51.46M |
| Liabilities | $194.15M |
| Current Liabilities | $45.53M |
| Accounts Payable | $12.86M |
| Wages | $7.77M |
| Other Current Liabilities | $24.90M |
| Noncurrent Liabilities | $148.62M |
| Equity | $157.38M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $157.38M |
| Liabilities And Equity | $351.53M |
| Net Cash Flow From Operating Activities | -$136.01M |
| Net Cash Flow From Operating Activities, Continuing | -$136.01M |
| Net Cash Flow From Investing Activities | -$506.00K |
| Net Cash Flow From Investing Activities, Continuing | -$506.00K |
| Net Cash Flow From Financing Activities | $178.30M |
| Net Cash Flow From Financing Activities, Continuing | $178.30M |
| Net Cash Flow | $41.79M |
| Net Cash Flow, Continuing | $41.79M |
| Comprehensive Income/Loss | -$229.97M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$229.97M |
| Other Comprehensive Income/Loss | -$229.97M |
| Other Comprehensive Income/Loss Attributable To Parent | $0.00 |